Please assess the completion status of the following clinical trial:

Trial Title: Fucidin® Cream in the Treatment of Impetigo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a clinical diagnosis of impetigo,~* Patients aged 2-11 years,~* Patients of either sex,~* Patients whose parent(s) has(ve) provided written consent, AND~* Patients with a severity score of 1 for at least one of the following signs: pustules/infected bullae, erythema and infiltration/induration.~Exclusion Criteria:~* Patients with other active inflammatory dermatitis at the area of impetigo,~* Patients with a temperature above 38.5 C rectally (or equivalent), OR~* Patients who have been administered topical or systemic Fucidin® or other antibacterial agents within the previous 4 weeks.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Fucidin® cream (Type: EXPERIMENTAL): None
- Fucidin® cream vehicle (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).